Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 14, 2025 • 10:00 PM ET

Date/Time Source News Release
05/13/2025 11:00 AM EDT GlobeNewswire Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit
05/09/2025 04:05 PM EDT GlobeNewswire Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
02/27/2025 04:05 PM EST GlobeNewswire Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
12/06/2024 05:30 PM EST GlobeNewswire Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association's 35th International Symposium on ALS/MND
11/07/2024 04:05 PM EST GlobeNewswire Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates
10/22/2024 07:00 AM EDT GlobeNewswire Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Meeting
09/17/2024 09:00 AM EDT GlobeNewswire Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
09/03/2024 04:01 PM EDT GlobeNewswire Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer's Disease
08/01/2024 04:05 PM EDT GlobeNewswire Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
07/31/2024 08:05 AM EDT GlobeNewswire Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer's Disease-Related Pathology at the Alzheimer's Association International Conference (AAIC) 2024
Page

Additional News

As of June 14, 2025 • 10:00 PM ET

Date/Time Source News Release
05/11/2025 05:30 AM EDT US Earnings Reports Expected earnings - Athira Pharma Inc.
05/09/2025 04:31 PM EDT SeekingAlpha Athira Pharma GAAP EPS of -$0.23 beats by $0.01
02/27/2025 05:35 PM EST SeekingAlpha Athira Pharma GAAP EPS of -$2.52 beats by $0.02
02/27/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, February 27th, 2025
02/27/2025 04:30 AM EST US Earnings Reports Expected earnings - Athira Pharma Inc.
02/24/2025 04:20 PM EST SeekingAlpha Terns Pharmaceuticals appoints new CFO
01/30/2025 08:32 AM EST SeekingAlpha Alterity surges after mid-stage trial data for lead asset
12/04/2024 07:54 AM EST SeekingAlpha Athena Gold upsizes private placement from C$1M to up to C$1.25M
11/09/2024 04:34 AM EST US Earnings Reports Expected earnings - Athira Pharma Inc.
11/08/2024 12:24 AM EST SeekingAlpha Athira Pharma GAAP EPS of -$0.75 misses by $0.04
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.